Sign in
CompletedNo phase

Design Improvements With SONNET 3

Key facts

Who runs it
Med-El Corporation
Where
Chapel Hill, United StatesSee the site
Trial code
Status
Completed
People taking part
20 people enrolled
Started
16 Dec 2024
Ended
31 Jul 2025
Type of study
Interventional
Treatments tested
  • Audio processor
Record updated
31 December 2025

Who can take part

Age
7 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (10)Hide the full registry criteria

Who can take part

  • Implanted with a MED-EL cochlear implant in at least one ear
  • ≥ 12 months since activation of the MED-EL audio processor
  • Consistently using a SONNET (EAS) or SONNET 2 (EAS) Audio Processor
  • Ability to complete all study procedures
  • Participant and parental (if applicable) commitment to comply with all study procedures for the duration of the study

Who cannot take part

  • Unable to provide reliable feedback during cochlear implant programming
  • Skin or scalp condition precluding use of the study device
  • Evidence that hearing loss is retrocochlear in origin
  • Unrealistic participant or parent (if applicable) motivation or expectations
  • Participants without a stable fitting map at enrollment e.g., due to changes in hearing, global health status, etc

Where in United States

  • University of North CarolinaChapel Hill, United States

About the trial

What the trial wants to find out

Measuring user-reported satisfaction with the latest behind-the-ear (BTE) audio processor model.

The group in the trial

  • SONNET 3 (EAS)Treatment being tested

    Participants complete a take-home trial using SONNET 3 (EAS) audio processor

    Treatment: Audio processor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Evaluating Design Improvements With SONNET 3 in Experienced Cochlear Implant Users
Record updated
31 December 2025